Skip to main content

Advertisement

ADVERTISEMENT

AMP 2023

Latest Results of the PROMISE II US Pivotal Trial of the LimFlow System

In this video recorded at AMP 2023, interventional cardiologist Zola N'Dandu, MD, discusses his presentation on the latest results of the PROMISE II U.S. Pivotal Trial, which investigated the safety and effectiveness of the LimFlow System for the treatment of chronic limb-threatening ischemia in patients ineligible for conventional endovascular or surgical limb salvage procedures.

 

Advertisement

Advertisement

Advertisement